CUTANEOUS T CELL LYMPHOMA (CTCL)
Clinical trials for CUTANEOUS T CELL LYMPHOMA (CTCL) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS T CELL LYMPHOMA (CTCL) trials appear
Sign up with your email to follow new studies for CUTANEOUS T CELL LYMPHOMA (CTCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare skin lymphoma: drug after transplant may stop cancer return
Disease control Not yet recruitingThis study tests whether giving brentuximab vedotin after a stem cell transplant can prevent early relapse in people with advanced cutaneous T-cell lymphoma (CTCL). About 84 adults aged 18-70 with CD30-positive mycosis fungoides who have had at least one prior treatment and are i…
Matched conditions: CUTANEOUS T CELL LYMPHOMA (CTCL)
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New hope for rare skin cancer: safer chemo combo enters human trials
Disease control Not yet recruitingThis study tests a new combination of drugs (CAOP) for people with cutaneous T-cell lymphoma (CTCL) that has come back or not responded to prior treatment. The goal is to find the safest dose and see if the treatment shrinks tumors. About 37 adults aged 60 and older will take par…
Matched conditions: CUTANEOUS T CELL LYMPHOMA (CTCL)
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New antibody targets Hard-to-Treat skin cancer in first human trial
Disease control Not yet recruitingThis early-phase trial tests a new drug, DT-7012, for people with advanced cutaneous T-cell lymphoma (CTCL) that has not responded to other treatments. The drug is an antibody designed to seek out and destroy cancer cells in the skin while also helping the immune system fight the…
Matched conditions: CUTANEOUS T CELL LYMPHOMA (CTCL)
Phase: EARLY_PHASE1 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 18, 2026 12:09 UTC